The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
Hyun Kuk Kim(Seoul National University Hospital), Young‐Hoon Jeong(Chung-Ang University Hospital), Paul A. Gurbel(Sinai Hospital), Satoshi Yasuda(Tohoku University), Wen‐Jone Chen(Min Sheng General Hospital), Duk‐Woo Park(Ulsan College), Do‐Sun Lim(Korea University), Shinya Goto(Tokai University), Gregory Y.H. Lip(Medical University of Białystok), Dominick J. Angiolillo(University of Florida), Diana A. Gorog(University of Hertfordshire), Sidney C. Smith(University of North Carolina at Chapel Hill), Mark Y. Chan(National University Heart Centre Singapore), Bo Zheng(Peking University), Dirk Sibbing(Ludwig-Maximilians-Universität München), Yong Huo(Sun Yat-sen University), Eun‐Seok Shin(Ulsan University Hospital), Moo Hyun Kim(Yonsei University), Tobias Geisler(Imperial College London), Takeshi Kimura(Municipal Hirakata City Hospital), Seung‐Jung Park(Samsung Medical Center), Shao-Liang Chen(Nanjing Medical University), Udaya S. Tantry(Sinai Hospital), Myung Ho Jeong(Veterans Health Service Medical Center), Dániel Aradi(HUN-REN Balaton Limnological Research Institute)
Cited by 334
Related Papers
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k